-+ 0.00%
-+ 0.00%
-+ 0.00%

Nihon Kohden (TSE:6849) Stock Faces Profit Squeeze After Quarterly Loss

Simply Wall St·08/07/2026 13:44:38
Listen to the news

Nihon Kohden stock has drifted lower in recent weeks despite a headline P/E of 16.8x and a market price that sits below a discounted cash flow fair value estimate. Today’s Q1 2027 report gives you the real story. The headline is a swing into a quarterly loss, with basic earnings per share turning negative and net income slipping into the red, even as the trailing 12 month figures remain profitable.

For investors, the key question now is how that margin squeeze fits with a multi year record of weaker earnings and the current valuation gap.

Is Nihon Kohden a genuine value opportunity after a quarterly loss, or is the cheaper share price simply catching up with weaker earnings trends? See how its current market price compares with intrinsic worth in our valuation analysis for Nihon Kohden

Q1 2027 Earnings Summary

  • Total Revenue (Q1 2027 vs Q1 2026): ¥47,405m vs. ¥50,020m (revenue declined 5.2%)
  • Net Income or Loss (Q1 2027 vs Q1 2026): loss of ¥756m vs. profit of ¥137m (moved from profit into loss)
  • Basic EPS (Q1 2027 vs Q1 2026): loss of ¥4.73 per share vs. profit of ¥0.84 per share (moved from profit into loss)
  • Trailing 12 Month Net Income (Q1 2027 TTM vs Q1 2026 TTM): ¥13,620m vs. ¥13,469m (broadly stable profit level on a trailing 12 month view)

Prefer clean charts over scrolling through another wall of earnings tables and ratios? See Nihon Kohden’s full visual breakdown, including how its valuation compares with recent earnings pressure, in our company report for Nihon Kohden.

TSE:6849 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026
TSE:6849 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026

Nihon Kohden bullish story meets profit resilience test

The latest quarter challenges the idea of Nihon Kohden as a straightforward defensive compounder, since revenue fell 5.2% year on year and quarterly profit turned into a loss. However, the trailing 12 month net income of ¥13,620m is broadly stable versus the prior year. That supports the view that the installed base and consumables still provide some earnings resilience. Recent steps such as cancelling 3,000,000 treasury shares in June 2026 also point to a balance sheet that can support long term capital management even as near term earnings soften.

Short term earnings slip underscores bear case concerns

The bearish angle around price pressure and hospital capex risk finds support here. Revenue declined and Nihon Kohden moved from a quarterly profit of ¥137m to a loss of ¥756m, with basic EPS swinging into loss territory. That shift lines up with concerns about margin pressure in competitive tenders. Recent share price performance, down about 10% over 7 days and 5% over 30 days, suggests investors are already reacting to these weaker quarterly trends despite the still profitable 12 month earnings base.

With quarterly earnings slipping into loss while the trailing 12 month profit line holds steady, the real question is how much balance sheet flexibility Nihon Kohden actually has. Check the full solvency and liquidity breakdown in our financial health analysis of Nihon Kohden stock.

Stay Ahead With Simply Wall St

If Nihon Kohden is now on your radar after its recent quarterly loss and valuation gap, register for free with Simply Wall St and add it to your Watchlist to track price moves against fair value and wait for a setup that fits your plan. When you decide to take a position, keep on top of Nihon Kohden and the rest of your holdings with the Portfolio Command Center that filters out noise and highlights the updates that matter. For longer term context, use the Community to see how other investors are thinking about risks, catalysts and expectations. That combination helps you spot potential turning points early and stay ahead of the market instead of reacting late.

Seeking Alternatives Beyond Nihon Kohden

Fresh stock ideas can move from quiet buildup to breakout momentum quickly. Spot under the radar opportunities before the crowd while the data still matters. Get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.